Twenty four asymptomatic HAART-treated HIV-@ + patients were enrolled in a phase I clinical study and were randomized to three groups : @ groups were treated with five IM injection ( Arm A : @g/inoculation ; Arm B : @g/inoculation ) at day ( D ) D@ , D@ , D@ , D@ and D@ ; the control group ( Arm C ) were not injected .